MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 32 (9) , 984-987
- https://doi.org/10.1053/hupa.2001.27113
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Pathology of Uterine Smooth Muscle Tumors and Mixed Endometrial Stromal-Smooth Muscle Tumors: A Selective Review with Emphasis on Recent AdvancesInternational Journal of Gynecological Pathology, 2000
- Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterusBritish Journal of Cancer, 1999
- Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterusInternational Journal of Cancer, 1999
- Expression of Steroid Receptors, Ki-67, and p53 in Uterine LeiomyosarcomasInternational Journal of Gynecological Pathology, 1999
- Uterine Leiomyosarcoma Has Deregulated Cell Proliferation, but Not Increased Microvessel Density Compared with Uterine LeiomyomaGynecologic Oncology, 1997
- Analysis of Ki-ras, p53, and MDM2 Genes in Uterine Leiomyomas and LeiomyosarcomasGynecologic Oncology, 1997
- Proliferation, ploidy and prognosis in uterine smooth muscle tumoursHistopathology, 1996
- Immunohistochemistry (Ki‐67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus)APMIS, 1996
- Leiomyosarcoma Versus Bizarre and Cellular Leiomyomas of the UterusInternational Journal of Gynecological Pathology, 1995